Higher baseline cardiorespiratory fitness is associated with lower arrhythmia recurrence and death after atrial fibrillation ablation.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
10 2020
Historique:
received: 08 04 2020
revised: 30 04 2020
accepted: 04 05 2020
pubmed: 9 8 2020
medline: 15 9 2021
entrez: 9 8 2020
Statut: ppublish

Résumé

Cardiorespiratory fitness (CRF) has been shown to correlate with incident atrial fibrillation (AF) and AF burden. In recent years there has been increasing recognition of the pivotal role of modifying risk factors before AF ablation. The purpose of this study was to investigate whether higher baseline CRF measured using exercise stress testing (EST) was associated with improved outcomes after AF ablation. We studied 591 patients who underwent EST within 12 months before AF ablation. Patients were categorized into low (<85% predicted), adequate (85%-100% predicted), and high (>100% predicted) CRF groups. Outcomes of interest included arrhythmia recurrence, cessation of antiarrhythmic therapy, repeat hospitalization for arrhythmia, repeat rhythm control procedures, and all-cause mortality. During mean follow-up of 32 months after ablation, arrhythmia recurrence was observed in 79% of patients in the low CRF group compared to 54% in the adequate CRF group and 27.5% in the high CRF group (P <.0001). Similarly, rates of repeat arrhythmia-related hospitalization, repeat rhythm control procedures, and need for ongoing antiarrhythmic therapy were significantly lower in the high CRF group (P <.0001). Death occurred in 2.5% of patients in the high CRF group compared to 4% in the adequate CRF group and 11% in the low CRF group (P <.0001). In Cox proportional hazards analyses, high CRF was significantly associated with lower arrhythmia recurrence. Higher CRF is associated with reduced arrhythmia recurrence rates and death among patients undergoing AF ablation. Efforts should be made to enhance CRF before AF ablation.

Sections du résumé

BACKGROUND
Cardiorespiratory fitness (CRF) has been shown to correlate with incident atrial fibrillation (AF) and AF burden. In recent years there has been increasing recognition of the pivotal role of modifying risk factors before AF ablation.
OBJECTIVE
The purpose of this study was to investigate whether higher baseline CRF measured using exercise stress testing (EST) was associated with improved outcomes after AF ablation.
METHODS
We studied 591 patients who underwent EST within 12 months before AF ablation. Patients were categorized into low (<85% predicted), adequate (85%-100% predicted), and high (>100% predicted) CRF groups. Outcomes of interest included arrhythmia recurrence, cessation of antiarrhythmic therapy, repeat hospitalization for arrhythmia, repeat rhythm control procedures, and all-cause mortality.
RESULTS
During mean follow-up of 32 months after ablation, arrhythmia recurrence was observed in 79% of patients in the low CRF group compared to 54% in the adequate CRF group and 27.5% in the high CRF group (P <.0001). Similarly, rates of repeat arrhythmia-related hospitalization, repeat rhythm control procedures, and need for ongoing antiarrhythmic therapy were significantly lower in the high CRF group (P <.0001). Death occurred in 2.5% of patients in the high CRF group compared to 4% in the adequate CRF group and 11% in the low CRF group (P <.0001). In Cox proportional hazards analyses, high CRF was significantly associated with lower arrhythmia recurrence.
CONCLUSION
Higher CRF is associated with reduced arrhythmia recurrence rates and death among patients undergoing AF ablation. Efforts should be made to enhance CRF before AF ablation.

Identifiants

pubmed: 32762978
pii: S1547-5271(20)30434-3
doi: 10.1016/j.hrthm.2020.05.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1687-1693

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Eoin Donnellan (E)

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

Oussama M Wazni (OM)

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

Serge Harb (S)

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

Mohamed Kanj (M)

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

Walid I Saliba (WI)

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

Wael A Jaber (WA)

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio. Electronic address: jaberw@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH